Genenta Science SPA

詳細情報 Genenta Science SPA 企業名

Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.

企業情報

企業コードGNTA

会社名Genenta Science SPA

上場日Dec 15, 2021

最高経営責任者「CEO」Mr. Pierluigi Paracchi

従業員数13

証券種類Depository Receipt

決算期末Dec 15

本社所在地Via Olgettina 58

都市MILANO

証券取引所NASDAQ Capital Market Consolidated

国Italy

郵便番号20132

電話番号

ウェブサイトhttps://www.genenta.com/

企業コードGNTA

上場日Dec 15, 2021

最高経営責任者「CEO」Mr. Pierluigi Paracchi

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Pierluigi Paracchi

Chairman of the Board, Chief Executive Officer, General Manager

2.30M

-0.13%

Dr. Carlo Russo, M.D.

Chief Medical Officer, Head of Development

602.42K

+0.67%

Mr. Richard B. Slansky

Chief Financial Officer

22.15K

+11.03%

Dr. Lauren Haeyong Chung, Ph.D.

Independent Director

--

Dr. John Louis Cantello, Ph.D.

Independent Director

--

Dr. Armon Reza Sharei, Ph.D.

Independent Director

--

Dr. Todd Wider, M.D.

Independent Director

--

Ms. Barbara Regonini

Finance Director

--

-100.00%

Dr. Stefania Mazzoleni, Ph.D.

Scientific Project Manager, Communication Officer

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Pierluigi Paracchi

Chairman of the Board, Chief Executive Officer, General Manager

2.30M

-0.13%

Dr. Carlo Russo, M.D.

Chief Medical Officer, Head of Development

602.42K

+0.67%

Mr. Richard B. Slansky

Chief Financial Officer

22.15K

+11.03%

Dr. Lauren Haeyong Chung, Ph.D.

Independent Director

--

Dr. John Louis Cantello, Ph.D.

Independent Director

--

Dr. Armon Reza Sharei, Ph.D.

Independent Director

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Sat, May 17

株主統計

種類

株主統計

比率

Paracchi (Pierluigi)

12.55%

IRCCS Ospedale San Raffaele

10.37%

Naldini (Luigi M.D., Ph.D.)

7.58%

Gentner (Bernard)

3.79%

Russo (Carlo)

3.29%

Other

62.41%

株主統計

比率

Paracchi (Pierluigi)

12.55%

IRCCS Ospedale San Raffaele

10.37%

Naldini (Luigi M.D., Ph.D.)

7.58%

Gentner (Bernard)

3.79%

Russo (Carlo)

3.29%

Other

62.41%

種類

株主統計

比率

Individual Investor

27.50%

Corporation

10.37%

Investment Advisor

5.67%

Investment Advisor/Hedge Fund

2.53%

Sovereign Wealth Fund

1.60%

Holding Company

1.28%

Hedge Fund

0.55%

Research Firm

0.02%

Other

50.48%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

24

9.06M

49.52%

-130.50K

2025Q1

28

9.12M

49.85%

-26.40K

2024Q4

28

8.70M

47.57%

-293.74K

2024Q3

26

8.60M

47.05%

-368.88K

2024Q2

26

8.48M

46.40%

-155.29K

2024Q1

25

8.51M

46.63%

+417.20K

2023Q4

25

8.38M

45.98%

+434.51K

2023Q3

24

8.11M

44.52%

+167.75K

2023Q2

24

8.11M

44.52%

+601.69K

2023Q1

18

7.50M

41.20%

+4.74M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Paracchi (Pierluigi)

2.30M

12.55%

-3.10K

-0.13%

Mar 26, 2025

IRCCS Ospedale San Raffaele

1.90M

10.37%

--

Mar 26, 2025

Naldini (Luigi M.D., Ph.D.)

1.39M

7.58%

--

Mar 26, 2025

Gentner (Bernard)

692.87K

3.79%

--

Mar 26, 2025

Russo (Carlo)

602.42K

3.29%

+4.00K

+0.67%

Mar 26, 2025

Eurizon Capital SGR S.p.A.

360.00K

1.97%

--

May 31, 2025

Kairos Partners SGR S.p.A.

335.63K

1.84%

-248.00

-0.07%

Mar 31, 2025

Norges Bank Investment Management (NBIM)

292.84K

1.6%

-14.36K

-4.68%

Dec 31, 2024

Investitori SGR S.p.A.

233.55K

1.28%

--

May 31, 2025

Allianz SE

233.55K

1.28%

+130.30K

+126.20%

Mar 31, 2025

詳細を見る

3.772USD

Genenta Science SPA

3.772

概要

企業名

金融